Intrinsic Value of S&P & Nasdaq Contact Us

Olema Pharmaceuticals, Inc. OLMA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
59/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$42.50
+160.7%

Stock Statistics — OLMA

Olema Pharmaceuticals, Inc. (OLMA) has a market capitalization of $1.42B and trades at $16.30. The 52-week range is 2.86-36.259.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.7, Earnings Per Share (EPS) of $-1.87.

The stock has a beta of 2.18, operates in the Healthcare sector.

Trading Data
Current Price$16.30
52-Week Range2.86-36.259
Volume769.97K
Avg Volume (30D)1.62M
Market Cap$1.42B
Beta (1Y)2.18
Company
IPO Date2020-11-19
Employees96
CEOSean Bohen
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS68062P1066
CUSIP68062P106
Income (Latest Year)
EBITDA$-178.21M
Operating Income$-178.7M
Net Income$-162.45M
EPS$-1.87
EPS Diluted$-1.87
Shares Outstanding$87.01M
Balance Sheet (Latest Year)
Total Assets$533.43M
Current Assets$515.45M
Cash & ST Investments$505.44M
Total Liabilities$54.87M
Total Debt$1.19M
Net Debt$-47.11M
Total Equity$478.56M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-8.7
P/B Ratio2.97
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message